EUVIMEDEUVIMED entdecken
Crossref

A Study on the Mechanism of Action of Hyperoside in Treating Type 2 Diabetes: Integrating Metabolomics, Network Pharmacology, Molecular Docking, and Experimental Validation

Yueqi Zhao, Yue Yang, Ying Li, Xiaoyu Li, Siyu Hou, Chunlei Wan iD, Shiming Wang, Qila Sa iD, Lei Zhang iD

Chemistry & Biodiversity · 2026-04 · 23 (4)

DOI: 10.1002/cbdv.71188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 17.04.2026. Verfasst von Yueqi Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China. Hauptthemen laut MEDLINE: Quercetin, Molecular Docking Simulation, Diabetes Mellitus, Type 2, Metabolomics. Die Arbeit nennt 71 Literaturangaben. Gefördert von: Heilongjiang Provincial Natural Science Foundation-funded Project "Study on the Mechanism of Vegetation Restoration in Lava Plateaus Based on Plant Functional…, Basic scientific research operating expenses of provincial universities in Heilongjiang Province, College Students Innovation and Entrepreneurship Training Program of Mudanjiang Normal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM), a chronic metabolic disorder caused by genetic and environmental factors, is characterized by insulin resistance and impaired pancreatic β‐cell function. Hyperoside, a natural flavonol glycoside, exerts anti‐T2DM effects, but its mechanism remains unclear. This study established T2DM mouse models via a high‐fat/high‐sugar diet and streptozotocin injection, detecting body weight, blood glucose, and biochemical indicators. Combined metabolomics, network pharmacology, in‐vitro experiments, and molecular docking were used to explore its therapeutic targets and mechanisms. Pharmacodynamic studies confirmed hyperoside's hypoglycemic and symptom‐improving effects. Nontargeted metabolomics identified 15 diabetes‐related biomarkers, revealing hyperoside may regulate primary bile acid biosynthesis and glycerophospholipid metabolism via specific targets. Network pharmacology screened 161 core targets, with SRC, PTPN11, and EGFR as key ones via KEGG enrichment analysis. Molecular docking verified hyperoside's favorable binding affinity to these targets. In conclusion, hyperoside has a good therapeutic effect on T2DM, possibly by regulating the above metabolic pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinMolecular Docking SimulationDiabetes Mellitus, Type 2MetabolomicsHypoglycemic AgentsDiabetes Mellitus, ExperimentalAnimalsMiceNetwork PharmacologyMale

Stichwörter der Autor:innen

experimental verificationhyperosidemetabolomicsmolecular dockingnetwork pharmacologytype 2 diabetes mellitus

Substanzen

QuercetinhyperosideHypoglycemic Agents

Autor:innen und Institutionen

  • College of Life Science and Technology, Mudanjiang Normal University, Mudanjiang, China.
  • College of Food Science and Technology, Hainan University, Haikou, China.
  • Medicine Innovation Center For Nationalities, Inner Mongolia Medical University, Hohhot, China.

ORCID-Profile: Chunlei Wan, Qila Sa, Lei Zhang

Förderung

  • Heilongjiang Provincial Natural Science Foundation-funded Project "Study on the Mechanism of Vegetation Restoration in Lava Plateaus Based on Plant Functional…
  • Basic scientific research operating expenses of provincial universities in Heilongjiang Province
  • College Students Innovation and Entrepreneurship Training Program of Mudanjiang Normal University

Zitieren

APA

Zhao, Y., Yang, Y., Li, Y., Li, X., Hou, S., Wan, C., Wang, S., Sa, Q., & Zhang, L. (2026). A Study on the Mechanism of Action of Hyperoside in Treating Type 2 Diabetes: Integrating Metabolomics, Network Pharmacology, Molecular Docking, and Experimental Validation. Chemistry & Biodiversity, 23(4). https://doi.org/10.1002/cbdv.71188

Vancouver

Zhao Y, Yang Y, Li Y, Li X, Hou S, Wan C, et al. A Study on the Mechanism of Action of Hyperoside in Treating Type 2 Diabetes: Integrating Metabolomics, Network Pharmacology, Molecular Docking, and Experimental Validation. Chemistry & Biodiversity. 2026;23(4). doi:10.1002/cbdv.71188

BibTeX
@article{Zhao2026,
  author = {Zhao, Yueqi and Yang, Yue and Li, Ying and Li, Xiaoyu and Hou, Siyu and Wan, Chunlei and Wang, Shiming and Sa, Qila and Zhang, Lei},
  title = {A Study on the Mechanism of Action of Hyperoside in Treating Type 2 Diabetes: Integrating Metabolomics, Network Pharmacology, Molecular Docking, and Experimental Validation},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {4},
  doi = {10.1002/cbdv.71188}
}
Kostenlos starten →